Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
| Actual shortage: | 212 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 297 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
85 (40%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-RANITIDINE | 150MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1510 |
| TEVA-RANITIDINE | 300MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1522 |
| TEVA-RANITIDINE | 300MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1534 |
| TEVA-RASAGILINE | 1MG | TABLET | Resolved | 2017-05-23 | 2017-09-19 | 10902 |
| TEVA-RASAGILINE | 1MG | TABLET | Actual shortage | 2025-05-08 | 2025-05-11 | 256926 |
| TEVA-RASAGILINE | 1MG | TABLET | Resolved | 2020-09-17 | 2020-11-26 | 124474 |
| TEVA-RASAGILINE | 0.5MG | TABLET | Resolved | 2020-01-17 | 2020-06-04 | 103587 |
| TEVA-RASAGILINE | 1MG | TABLET | Resolved | 2020-01-17 | 2020-06-18 | 103590 |
| TEVA-RASAGILINE | 1MG | TABLET | Resolved | 2022-06-09 | 2022-08-09 | 162280 |
| TEVA-RASAGILINE | 1MG | TABLET | Resolved | 2021-12-17 | 2021-12-22 | 151445 |
| TEVA-RASAGILINE | 1MG | TABLET | Resolved | 2018-03-13 | 2018-05-31 | 42626 |
| TEVA-RISEDRONATE | 35MG | TABLET | Resolved | 2018-03-16 | 2018-07-30 | 43138 |
| TEVA-RISEDRONATE | 5MG | TABLET | Resolved | 2019-06-18 | 2019-07-16 | 86911 |
| TEVA-RISEDRONATE | 35MG | TABLET | Resolved | 2020-02-07 | 2020-04-09 | 105561 |
| TEVA-RISEDRONATE | 150MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1607 |
| TEVA-RISEDRONATE | 5MG | TABLET | Resolved | 2020-03-26 | 2020-04-09 | 109592 |
| TEVA-RISEDRONATE | 35MG | TABLET | Resolved | 2020-04-03 | 2020-04-09 | 110776 |
| TEVA-RISEDRONATE | 30MG | TABLET | Resolved | 2021-10-21 | 2021-12-17 | 147714 |
| TEVA-RISEDRONATE | 35MG | TABLET | Resolved | 2022-06-03 | 2024-02-06 | 161973 |
| TEVA-RISEDRONATE | 5MG | TABLET | Resolved | 2022-06-30 | 2022-12-08 | 163948 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-12 | 2018-10-12 | 63943 |
| RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
| TEVA-LENOLTEC NO. 1 | 300MG 8MG 15MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81362 |
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-METFORMIN | 850MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 120012 |
| RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2019-10-25 | 2019-10-26 | 97243 |
| RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-02-13 | 2020-02-13 | 106148 |
| RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2019-10-25 | 2019-10-26 | 97261 |
| RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
| RATIO-TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Discontinued | 2018-10-19 | 2018-10-19 | 64917 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Discontinued | 2024-06-28 | 2024-06-29 | 231583 |
| TEVA-ACYCLOVIR | 800MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256128 |
| TEVA-ACYCLOVIR | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256122 |
| TEVA-ACYCLOVIR | 400MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256125 |
| TEVA-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2020-10-22 | 2020-10-24 | 126903 |
| TEVA-AMITRIPTYLINE | 50MG | TABLET | Discontinued | 2020-10-22 | 2020-10-24 | 126900 |
| TEVA-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2022-01-07 | 2022-01-07 | 152351 |
| TEVA-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2020-09-24 | 2020-09-24 | 124896 |
| TEVA-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2022-01-07 | 2022-01-07 | 152375 |